Nautilus Biotechnolgy's market cap is currently $200.90M. The company's EPS TTM is $-0.56; its P/E ratio is ―; Nautilus Biotechnolgy is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -5.71M	$ -3.42M	$ -2.84M	$ -2.35M	$ 0.00
Operating Income	$ -76.15M	$ -63.62M	$ -50.50M	$ -15.74M	$ -10.11K
EBITDA	$ -74.30M	$ -54.51M	$ -47.47M	$ -13.27M	$ -9.56M
Net Income	$ -63.67M	$ -63.74M	$ -50.31M	$ -15.62M	$ -9.62K
Balance Sheet
Cash & Short-Term Investments	$ 173.42M	$ 184.47M	$ 345.73M	$ 76.74M	$ 16.66M
Total Assets	$ 305.56M	$ 350.05M	$ 398.45M	$ 85.01M	$ 18.54M
Total Debt	$ 34.63M	$ 30.33M	$ 30.03M	$ 4.78M	$ 275.00M
Net Debt	$ 15.23M	$ -84.19M	$ -155.59M	$ -31.83M	$ 274.40M
Total Liabilities	$ 40.21M	$ 35.13M	$ 34.87M	$ 114.73M	$ 490.00K
Stockholders' Equity	$ 265.35M	$ 314.92M	$ 363.58M	$ -29.72M	$ 18.05M
Cash Flow
Free Cash Flow	$ -54.15M	$ -48.13M	$ -41.51M	$ -14.92M	$ -10.59M
Operating Cash Flow	$ -51.71M	$ -45.81M	$ -39.24M	$ -14.00M	$ -9.66M
Investing Cash Flow	$ -43.73M	$ -25.74M	$ -138.96M	$ -25.28M	$ 4.05M
Financing Cash Flow	$ 368.00K	$ 562.00K	$ 327.45M	$ 75.90M	$ 36.00K

Currency in USD

Nautilus Biotechnolgy Earnings and Revenue History

Income Statement >

Nautilus Biotechnolgy Debt to Assets

Balance Sheet >

Nautilus Biotechnolgy Cash Flow

Cash Flow >

Nautilus Biotechnolgy Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing